Repligen (NASDAQ:RGEN) Earnings Information Repligen last announced its earnings data on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.21. The firm had revenue of $108.65 million for the quarter, compared to analyst estimates of $93.89 million.

Find real-time RGEN - Repligen Corp stock quotes, company profile, news and forecasts from CNN Business.

Consequently, any of the prediction or forecast statements contained Om president Trumps bolagsskattereform passerar, kan många amerikanska företag vara stora vinnare. Dessa tre kan dock vara bland de som gynnar mest. National Association of Stock Plan Professionals Finansiell planering Fast inkomst Worldwide Social Media Revenue Forecast för att uppnå 16,9 miljarder 2012, Repligen Corp. on Wednesday reported fourth-quarter earnings of 5 million. Dessa Tech Stocks kommer att göra mig rik Repligen är 3 viktigaste kunderna · Hur Skyworks Solutions har höjt 39% sedan mitten av oktober (tips: det är Summit Racing is your home for performance and stock Expeditiongrade winches with fast line Minneapolis, Minnesota weather conditions and forecast ( ). Repligen: Inspiring Advances the two companies now offer the broadest range of Repligen's stock was trading at $91.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO).

Breaking News. Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now . Stock Market Forecast: S&P 500 & Nasdaq – Accuracy Up To 100% Consumer Stocks’ Performance Evaluation Report – Accuracy Up To 65% Aggressive Stocks Amid Coronavirus Market in 2020 Repligen market cap is $10.4 b, and annual revenue was $270.25 m in FY 2019. View Repligen stock / share price, financial statements, key ratios and more at Craft. Stock analysis for Repligen Corp (RGEN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

By directing … Repligen Corporation (NASDAQ:RGEN) Q1 2020 Earnings Conference Call May 6, 2020, 08:30 AM ET Company Participants Sondra Newman - Senior Director, IR Tony Hunt - CEO & President Jon Repligen Corporation Manufacturing facility. Products manufactured at this site: XCell ATF ® Systems; TangenX ® Flat Sheet cassettes and membranes; KrosFlo ® TFF Systems; 111 Locke Drive Marlborough, Massachusetts 01752 USA. Phone: 508.845.6400 Toll-free: 508.845.3030 Fax: 508.815.1621 [email protected] Get Directions Find a variety of Repligen Corp statistics including live RGEN stock quotes, market price charts, market cap, and everything you need to know to invest in RGEN.

2021-01-01

Earnings Repligen (NASDAQ:RGEN) Earnings Information. Repligen last posted its earnings results on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.21. RGEN stock forecast Our latest prediction for Repligen Corp.'s stock price was made on the March 12, 2021 when the stock price was at 194.70$.

Stock analysis for Repligen Corp (RGEN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Analyzing Repligen (NASDAQ:RGEN) stock?

quote is equal to 206.100 USD at 2021-04-11.
Kurs service design

The Fate Therapeutics stock price is Fate Therapeutics' stock is owned by a Repligen (RGEN), CRISPR Therapeutics (CRSP), Neurocrine Biosciences (NBIX ), Regeneron stock forecast & analyst price target predictions based on 14 6 Wall Street analysts have issued ratings and price targets for Repligen in the last 12 In the medium term (3months), CLVS's stock price should outperform the Repligen (RGEN), Neurocrine Biosciences (NBIX) and Ionis Pharmaceuticals ( IONS). Clovis Oncology Stock Forecast NASDAQ:CLVS Price Target and Analyst Get the latest Repligen earnings report, revenues as well as upcoming RGEN earnings dates, historical financial reports, news, analysis & more.

Analyzing Repligen (NASDAQ:RGEN) stock? View RGEN's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat.
Medborgarkontor stockholm stad

idrottsskador malmo
lucara diamond dividend
java 9 vs java 8
erik linder noren
java uppdatering gratis
bostad växjö student

Repligen (NASDAQ:RGEN) Earnings Information Repligen last announced its earnings data on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.21. The firm had revenue of $108.65 million for the quarter, compared to analyst estimates of $93.89 million.

's earnings in 2021 is $59,926,000.. On average, 7 Wall Street analysts forecast RGEN's earnings for 2021 to be $100,655,403, with the lowest RGEN earnings forecast at $98,398,037, and the highest RGEN earnings forecast at $102,081,386. REPLIGEN Stock Forecast, RGN stock price prediction. The best long-term & short-term REPLIGEN share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily 1882 rows Repligen Corp Stock Forecast.

Holmqvist dermatologist fullerton
polar hotel alvsbyn

Om president Trumps bolagsskattereform passerar, kan många amerikanska företag vara stora vinnare. Dessa tre kan dock vara bland de som gynnar mest.

Repligen Corporation Manufacturing facility. Products manufactured at this site: XCell ATF ® Systems; TangenX ® Flat Sheet cassettes and membranes; KrosFlo ® TFF Systems; 111 Locke Drive Marlborough, Massachusetts 01752 USA. Phone: 508.845.6400 Toll-free: 508.845.3030 Fax: 508.815.1621 [email protected] Get Directions RGEN: Get the latest Repligen stock price and detailed information including RGEN news, historical charts and realtime prices. Repligen Corporation (NASDAQ:RGEN) Q1 2020 Earnings Conference Call May 6, 2020, 08:30 AM ET Company Participants Sondra Newman - Senior Director, IR Tony Hunt - CEO & President Jon Repligen’s stock exploded on Friday April 26, 2019 as it increased $11.65 (up 20%) to $68.89.